Hunter Smith - Nov 12, 2021 Form 3 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
Director
Signature
/s/ Steven Weber, by power of attorney
Stock symbol
AGLE
Transactions as of
Nov 12, 2021
Transactions value $
$0
Form type
3
Date filed
11/16/2021, 03:32 PM
Next filing
Feb 11, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney. No securities are beneficially owned.